Arrowhead Pharmaceuticals, Inc. (ARWR)
NASDAQ: ARWR · Real-Time Price · USD
74.81
+1.33 (1.81%)
At close: May 1, 2026, 4:00 PM EDT
74.80
-0.01 (-0.01%)
After-hours: May 1, 2026, 6:46 PM EDT

Arrowhead Pharmaceuticals Ratios and Metrics

Millions USD. Fiscal year is Oct - Sep.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
May '26 Sep '25 Sep '24 Sep '23 Sep '22 Sep '21
10,4764,6802,4092,8833,5026,513
Market Cap Growth
631.96%94.27%-16.45%-17.66%-46.23%47.75%
Enterprise Value
10,2594,6632,6092,8693,2246,169
Last Close Price
74.8134.4919.3726.8733.0562.43
PE Ratio
50.71-3449.00-3.87-13.99-19.79-45.90
PS Ratio
9.605.64678.4511.9814.4047.10
PB Ratio
18.0810.0413.1910.638.7915.93
P/TBV Ratio
18.079.9012.7010.578.7415.84
P/FCF Ratio
32.5329.83-3.99-8.72-18.5444.08
P/OCF Ratio
30.8726.07-5.21-18.74-25.7338.02
EV/Sales Ratio
9.405.62734.6211.9213.2644.61
EV/EBITDA Ratio
31.5038.13-4.48-14.90-19.18-43.82
EV/EBIT Ratio
34.1347.41-4.34-13.99-18.06-41.39
EV/FCF Ratio
31.8629.72-4.32-8.68-17.0741.75
Debt / Equity Ratio
1.211.444.431.300.190.06
Debt / EBITDA Ratio
2.126.00-1.46-1.99-0.48-0.18
Debt / FCF Ratio
2.144.68-1.41-1.16-0.430.17
Net Debt / Equity Ratio
-0.17-0.101.08-0.07-0.74-0.84
Net Debt / EBITDA Ratio
-0.30-0.39-0.340.111.752.43
Net Debt / FCF Ratio
-0.31-0.30-0.330.061.56-2.32
Asset Turnover
0.830.660.000.330.350.22
Quick Ratio
2.894.036.343.832.722.58
Current Ratio
3.384.866.743.952.922.62
Return on Equity (ROE)
75.50%8.67%-254.98%-59.33%-42.67%-32.36%
Return on Assets (ROA)
21.04%4.55%-62.81%-28.51%-26.02%-24.18%
Return on Invested Capital (ROIC)
54.20%13.40%-182.08%-79.62%-64.84%-60.11%
Return on Capital Employed (ROCE)
27.62%8.83%-70.85%-33.80%-31.97%-28.51%
Earnings Yield
1.93%-0.03%-25.81%-7.15%-5.05%-2.18%
FCF Yield
3.07%3.35%-25.08%-11.47%-5.39%2.27%
Buyback Yield / Dilution
-10.94%-11.67%-12.21%-1.26%-1.62%-3.00%
Total Shareholder Return
-10.94%-11.67%-12.21%-1.26%-1.62%-3.00%
Updated Feb 5, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q